Convolvulus pluricaulis Choisy.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | C. microphyllus Sieb. C. prostratus Forsk. |
| Family | Convolvulaceae. |
| Habitat | Throughout India, ascending to 2,000 m in the Himalayas. |
| Ayurvedic | Shankhapushpi, Shankhaahvaa, Kshirapushpi, Maangalya Kusuma (whiteflowered). Blue-flowered var., Vishnukraanti, Vishnukraantaa, Vishnugandhi is equated with Evolvulus alsinoides Linn. |
| Unani | Sankhaahuli (blue-flowered) |
| Siddha / Tamil | Sivakraandi (whiteflowered), Vishnukraandi (blueflowered). |
| Action | Plant—brain tonic, tranquilizer used in nervine disorders, mental aberration, anxiety neurosis, internal haemorrhages, spermatorrhoea. Also astringent, antidysenteric, antispasmodic, antiphlogistic, febrifuge, alterative. Flowers—styptic, used for uterine bleeding. Leaf—antiasthmatic, used in chronic bronchitis. Root— used in gastric and duodenal ulcers, uterine affections and for promoting fertility. |
| Dosage | Whole plant—3–6 g powder. (API Vol. III.) |
| Taxonomic Cohort | Genus Convolvulus (3 documented species); Family Convolvulaceae (35 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Convolvulus pluricaulis (taxonomically cited with authority Choisy.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Convolvulaceae (primary family classification: Convolvulaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. microphyllus Sieb. C. prostratus Forsk, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout India, ascending to 2,000 m in the Himalayas.
Across classical and vernacular Indian systems of medicine, Convolvulus pluricaulis is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Shankhapushpi, Shankhaahvaa, Kshirapushpi, Maangalya Kusuma (whiteflowered). Blue-flowered var., Vishnukraanti, Vishnukraantaa, Vishnugandhi is equated with Evolvulus alsinoides Linn; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Sankhaahuli (blue-flowered); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Sivakraandi (whiteflowered), Vishnukraandi (blueflowered). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Convolvulus pluricaulis are: Plant—brain tonic, tranquilizer used in nervine disorders, mental aberration, anxiety neurosis, internal haemorrhages, spermatorrhoea. Also astringent, antidysenteric, antispasmodic, antiphlogistic, febrifuge, alterative. Flowers—styptic, used for uterine bleeding. Leaf—antiasthmatic, used in chronic bronchitis. Root— used in gastric and duodenal ulcers, uterine affections and for promoting fertility. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Convolvulus pluricaulis establish the following evidence base: The Ayurvedic Pharmacopoeia of India recommends the plant for epilepsy. The plant contains sankhpushpine alkaloids. The alcoholic (50%) extract of the plant, when administered to rats (through gastric intubation at different intervals), has shown enhanced neuropeptide synthesis of the brain. It induces an increase in brain protein content and increases acquisition efficiency. Evolvulus alsinoides contains pentatriacontane, triacontane and betasitosterol. Shankhapushpi Syrup (a compound containing C. pluricaulis, Centella asiatica, Nardostachys jatamansi, Nepeta hindostana, Nepeta elliptica and Onosma bracteatum), when administered with phenytoin, a modern antiepileptic drug, reduced not only antiepileptic activity of phenytoin but also lowered plasma phenytoin levels.
In specialized pharmacognostic classifications, Convolvulus pluricaulis is also recognized among important classical herbs with divergent regional plant sources across North and South Indian formularies.

Botanical Reference 1: Convolvulus prostratus — Botanical specimen

Botanical Reference 2: Convolvulus prostratus — Botanical specimen

Botanical Reference 3: Convolvulus pluricaulis — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Convolvulus comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Convolvulus arvensis (Action: Plant—cooling, anticonvulsant. Root—cathartic); Convolvulus scammonia (Action: Resin from rhizomes—hydragogue, Cathartic, administered in dropsy and anascara). Comparing Convolvulus pluricaulis alongside its congeners in genus Convolvulus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Convolvulaceae encompasses 35 documented medicinal species (1.93% of the 1,814-species flora). Other representative medicinal members of Convolvulaceae include: Argyreia speciosa (Vriddhadaaruka), Convolvulus arvensis (Bhadrabalaa), Convolvulus scammonia (Scammony), Cressa cretica (Rudanti), Cuscuta epithymum (Aakaashvalli). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 35 medicinal species of family Convolvulaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Convolvulus pluricaulis are prescribed as follows: Whole plant—3–6 g powder. (API Vol. III.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Convolvulus pluricaulis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.